News for 'Glaxo SmithKline Pharma'

Pharma power

Pharma power

Rediff.com26 Jun 2004

TCS, Infosys in Forbes 'Super 50' list

TCS, Infosys in Forbes 'Super 50' list

Rediff.com26 Jul 2016

Companies which have been dropped from the list include Tata Motors, Hindustan Unilever, MRF, Glaxo SmithKline Consumer Healthcare, Pfizer, Dr Reddy's Labs, Glenmark Pharmaceuticals, HDFC and Kotak Mahindra Bank

Sensex: Satyam out, Sun Pharma in

Sensex: Satyam out, Sun Pharma in

Rediff.com8 Jan 2009

The National Stock Exchange on Wednesday removed Satyam from its benchmark index Nifty and the IT firm will be replaced by Reliance Capital with effect from January 12.

Wockhardt launches Ondansetron in US

Wockhardt launches Ondansetron in US

Rediff.com28 Dec 2006

Wockhardt's US subsidiary, Wockhardt USA, has launched Ondansetron injection in the United States on December 26.

Drugs ban: Partial relief for Wockhardt, Glaxo & Griffon

Drugs ban: Partial relief for Wockhardt, Glaxo & Griffon

Rediff.com18 Mar 2016

The Delhi High Court on Friday stayed the ban on some fixed dose combination (FDC) drugs of Glaxo SmithKline, Wockhardt and Laboratories Griffon but said action against their sale could be taken in the absence of valid sale and marketing licence.

Which is India's largest pharma company?

Which is India's largest pharma company?

Rediff.com25 Sep 2003

Take the Rediff Biz Quiz and find out how much you know about various Indian pharmaceutical companies.

Why open offers aren't attractive for many investors

Why open offers aren't attractive for many investors

Rediff.com13 Oct 2014

Tendering the shares in an open offer will lead to higher taxation.